The Problem
A client with an infectious disease vaccine needed to build a global omnichannel strategy that included DOLs.
This was to maintain leadership status in existing markets and successfully launch in new markets considering its competitors launching.
The Solution
We analysed over 4K posts across 7 markets including the US, EU, South America and Oceania
Key Outcomes
01.10.2026 | Article
Dive into CREATION Intelligence and uncover congress intelligence...
By Jessica Fernandes
30.07.2026 | Webinar
See the latest features including AI overviews and data from X, Instagram and Bluesky
02.04.2026 | Webinar
What Online HCP Conversations in Lung Cancer Tell Us About 2026
19.02.2026 | Article
In the age of social media, influence extends beyond borders...
By Jessica Fernandes
19.02.2026 | Article
Digital channels have become central to professional discourse, peer-to-peer exchange and...
By Bernard Groen
19.02.2026 | Article
Trust is paramount and when it comes to influencing medical professional...
By Katie Kennedy
21.02.2024 | Case Study
Discovering what HCPs found important and what they saw as a opportunity for this product
21.02.2024 | Case Study
Increasing a client's online share of voice through listening better to the voice of HCPs
21.02.2024 | Case Study
Building an omnichannel strategy including DOLs for a vaccine in infectious disease
21.02.2024 | Case Study
Differentiating their product in a competitive market by partnering with DOLs in oncology
25.08.2023 | Case Study
An interactive DOL playbook was developed & designed, providing guidelines for global teams
13.07.2023 | Case Study
PAG collaboration led to first ever Twitter Spaces event during drug launch